首页> 外国专利> seen framstella new 4 '- or 5' - substituted thiazole - 2 '- oximetylenoxazolidinderivat

seen framstella new 4 '- or 5' - substituted thiazole - 2 '- oximetylenoxazolidinderivat

机译:见新出现的弗雷斯特氏菌4'-或5'-取代的噻唑-2'-肟基苯并恶唑烷

摘要

1-Amino-3-(4- or 5-substituted thiazol-2-oxy)-2-propanol and/or substituted amino derivatives thereof: 3-(4-or 5-substituted thiazon-2-oxy)-1,2-epoxypropane and 5-(4-or 5-substituted thiazol-2-oxy)-1,2-epoxypropane and 5-(4-or 5-substituted thiazol-2-oxymethylene)-oxazolidine and/or N- and/or -substituted oxazolidine derivatives thereof, generally represented by comound formulas: (I) (II) (III) wherein R1, R2, R5, R6, R7 and Z are the various substituents and methods of making such compounds. The compounds are characterized by an aminocarbonyl or carbonylamino type substituent at the 5- or 4-position on the thiazole ring. The above 1-amino-3-(4- or 5-substituted thiazol-2-oxy)-2-propanol and derivatives exhibit cardiovascular activity and are useful in the treatment of abnormal heart conditions in mammals. The 3-(4- or 5-substituted thiazol-2-oxy)-1,2-epoxypropanes are useful as intermediates for the aforementioned cardiovascular agents. The 5-(4- or 5-substituted thiazol2-oxymethylene)-oxazolidine and derivatives are intermediates for the aforementioned cardiovascular agents and further exhibit cardiovascular activity and thus are useful in the treatment of abnormal heart conditions in mammals. The 1amino-3-(4- or 5-substituted thiazol-2-oxy)-2-propanol and derivatives can be prepared by base or acid hydrolysis of the corresponding 5-(4- or 5-aminocarbonylthiazol-2-oxymethylene)-oxazolidine or derivative; or by treatment of the corresponding 3-(4- or 5-substituted thiazol-2-oxy)-2, 3epoxypropane or derivative with the desired amine or amine derivative.
机译:1-氨基-3-(4-或5-取代的噻唑-2-氧基)-2-丙醇和/或其取代的氨基衍生物:3-(4-或5-取代的噻唑-2-氧基)-1,2 -环氧丙烷和5-(4-或5-取代的噻唑-2-氧基)-1,2-环氧丙烷和5-(4-或5-取代的噻唑-2-氧亚甲基)-恶唑烷和/或N-和/或-取代的恶唑烷衍生物,通常由下列通式表示:(I)(II)(III)其中R1,R2,R5,R6,R7和Z为各种取代基和制备此类化合物的方法。该化合物的特征在于在噻唑环的5-或4-位上的氨基羰基或羰基氨基型取代基。上述的1-氨基-3-(4-或5-取代的噻唑-2-氧基)-2-丙醇及其衍生物具有心血管活性,可用于治疗哺乳动物的心脏病。 3-(4-或5-取代的噻唑-2-氧基)-1,2-环氧丙烷可用作上述心血管药物的中间体。 5-(4-或5-取代的噻唑2-氧亚甲基)-恶唑烷和衍生物是上述心血管药物的中间体,并进一步表现出心血管活性,因此可用于治疗哺乳动物的异常心脏病。可以通过相应的5-(4-或5-氨基羰基噻唑-2-氧亚甲基)-的碱或酸水解来制备1-氨基-3-(4-或5-取代的噻唑-2-氧基)-2-丙醇及其衍生物。恶唑烷或衍生物;或通过用所需的胺或胺衍生物处理相应的3-(4-或5-取代的噻唑-2-氧基)-2、3-环氧丙烷或衍生物。

著录项

  • 公开/公告号SE7706068L

    专利类型

  • 公开/公告日1977-05-24

    原文格式PDF

  • 申请/专利权人 SYNTEX INC;

    申请/专利号SE19770006068

  • 发明设计人 EDWARDS J A;

    申请日1977-05-24

  • 分类号C07D417/12;C07D263/04;

  • 国家 SE

  • 入库时间 2022-08-23 00:38:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号